Tag Archives: Abbott Labs

Wells Fargo Believes Abbott Labs (NYSE: ABT) Still Has Room to Grow

Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Abbott Labs (ABT – Research Report) today. The company’s shares opened today at $78.50, close to its 52-week high of $79.15. According to TipRanks.com, Biegelsen is a 5-star analyst with

Abbott Labs (NYSE: ABT) Executives are Making Moves with Their Shares

Today, the EVP of Abbott Labs (ABT – Research Report), Stephen Fussell, sold shares of ABT for $1.35M. Following Stephen Fussell’s last ABT Sell transaction on August 18, 2017, the stock climbed by 31.2%. In addition to Stephen Fussell, 7

Abbott Labs (ABT) Receives a Hold from BTIG

BTIG analyst Sean Lavin maintained a Hold rating on Abbott Labs (ABT – Research Report) yesterday. The company’s shares closed yesterday at $69.91. Lavin noted: “Q4 was a mixed bag with reported revenue and margin falling short of consensus’ expectations,

Morgan Stanley Sticks to Their Buy Rating for Abbott Labs (ABT)

Morgan Stanley analyst David Lewis maintained a Buy rating on Abbott Labs (ABT – Research Report) today and set a price target of $82. The company’s shares closed yesterday at $74.27, close to its 52-week high of $74.92. According to

Jefferies Keeps a Buy Rating on Abbott Labs (ABT)

Jefferies analyst Raj Denhoy reiterated a Buy rating on Abbott Labs (NYSE: ABT) on October 17 and set a price target of $80. The company’s shares closed on Friday at $67.59. According to TipRanks.com, Denhoy is a top 25 analyst

BTIG Maintains Their Hold Rating on Abbott Labs (ABT)

In a report released yesterday, Sean Lavin from BTIG maintained a Hold rating on Abbott Labs (NYSE: ABT). The company’s shares closed yesterday at $70.23. According to TipRanks.com, Lavin is a 5-star analyst with an average return of 12.8% and